216 related articles for article (PubMed ID: 6730855)
1. Prevention of hyponatraemia and cerebral oedema by the vasopressin antagonist d/CH2/5Tyr/Et/VAVP in rats treated with pitressin tannate.
László FA; Csáti S; Baláspiri L
Acta Endocrinol (Copenh); 1984 May; 106(1):56-60. PubMed ID: 6730855
[TBL] [Abstract][Full Text] [Related]
2. Effect of the vasopressin antagonist d(CH2)5 Tyr(Et)VAVP on diuresis in rat.
László FA; Csáti S; Baláspiri L; Manning M
Acta Med Hung; 1984; 41(1):65-73. PubMed ID: 6739224
[TBL] [Abstract][Full Text] [Related]
3. Experimental water intoxication induced by dDAVP in rat, and its prevention with the vasopressin antagonist d(CH2)5Tyr(Et)VAVP.
László FA; Baláspiri L
Acta Med Hung; 1986; 43(3):333-9. PubMed ID: 3588172
[TBL] [Abstract][Full Text] [Related]
4. Effect of the vasopressin antagonist d/CH2/5Tyr/Et/VAVP on the antidiuretic action of exogenous and endogenous vasopressin.
László FA; Csáti S; Baláspiri L
Acta Endocrinol (Copenh); 1984 May; 106(1):52-5. PubMed ID: 6730854
[TBL] [Abstract][Full Text] [Related]
5. [The effect of vasopressin analogs on water metabolism].
László F; Laczi F; Julesz J; Baláspiri L
Z Gesamte Inn Med; 1983 Nov; 38(22):248-50. PubMed ID: 6666181
[TBL] [Abstract][Full Text] [Related]
6. Prevention of cerebral edema by the vasopressin antagonist d(CH2)5D-Ile2Ile4Ala9AVP in rats with experimental subarachnoid hemorrhage.
László FA; Varga C; Baláspiri L
Ann N Y Acad Sci; 1993 Jul; 689():627-9. PubMed ID: 8373062
[No Abstract] [Full Text] [Related]
7. Mechanism of action and structural requirements of vasopressin analog inhibition of transepithelial water flux in toad urinary bladder.
Mann WA; Stassen F; Huffman W; Kinter LB
J Pharmacol Exp Ther; 1986 Aug; 238(2):401-6. PubMed ID: 3090234
[TBL] [Abstract][Full Text] [Related]
8. Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin.
Manning M; Lammek B; Kolodziejczyk AM; Seto J; Sawyer WH
J Med Chem; 1981 Jun; 24(6):701-6. PubMed ID: 7252979
[TBL] [Abstract][Full Text] [Related]
9. Effects of vasopressin antagonist on vasopressin binding, adenylate cyclase activation, and water flux.
Kim JK; Dillingham MA; Summer SN; Ishikawa S; Anderson RJ; Schrier RW
J Clin Invest; 1985 Oct; 76(4):1530-5. PubMed ID: 2997281
[TBL] [Abstract][Full Text] [Related]
10. Effect of vasopressin antagonist d(CH2)5Tyr(Et)VAVP on plasma arginine vasopressin level after osmotic stimulus.
László FA; Laczi F; Janáky T; Baláspiri L
Endocr Regul; 1991 Sep; 25(3):181-3. PubMed ID: 1764609
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the pharmacologic properties of a vasopressin antagonist in Brattleboro rats.
Mah SC; Hofbauer KG
J Pharmacol Exp Ther; 1988 Jun; 245(3):1028-32. PubMed ID: 2968448
[TBL] [Abstract][Full Text] [Related]
12. Development of the Schwartz-Bartter syndrome after the administration of chlorpropamide and 1-deamino-8-D-arginine vasopressin.
Valkusz Z; Laczi F; László FA
Endokrinologie; 1982 Jul; 79(3):345-8. PubMed ID: 7128548
[No Abstract] [Full Text] [Related]
13. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
14. Discovery and therapeutic utility of vasopressin antagonists in rats.
Kinter LB; Dytko G; Ashton D; McDonald J; Huffman W; Stassen F
J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S36-43. PubMed ID: 2434770
[TBL] [Abstract][Full Text] [Related]
15. Prevention of hypoxic brain oedema by the administration of vasopressin receptor antagonist OPC-31260.
Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
Prog Brain Res; 2008; 170():519-25. PubMed ID: 18655905
[TBL] [Abstract][Full Text] [Related]
16. Noncyclic vasopressin analogs are effective diuretics in conscious rats.
Uyehara CF; Caltabiano S; Kinter LB; Gellai M
J Pharmacol Exp Ther; 1989 Dec; 251(3):1128-33. PubMed ID: 2600807
[TBL] [Abstract][Full Text] [Related]
17. Benzamil prevents brain water accumulation in hyponatraemic rats.
Sulyok E; Pál J; Vajda Z; Steier R; Dóczi T
Acta Neurochir (Wien); 2009 Sep; 151(9):1121-5. PubMed ID: 19415169
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of vasopressin receptor antagonist OPC-31260 on experimental brain oedema induced by global cerebral ischaemia.
Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
Acta Neurochir (Wien); 2008 Mar; 150(3):265-71. PubMed ID: 18288441
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin receptor antagonist OPC-31260 prevents cerebral oedema after subarachnoid haemorrhage.
László FA; Varga C; Nakamura S
Eur J Pharmacol; 1999 Jan; 364(2-3):115-22. PubMed ID: 9932713
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).
Kinter LB; Churchill S; Stassen FL; Moore M; Huffman W
J Pharmacol Exp Ther; 1987 Jun; 241(3):797-803. PubMed ID: 3598903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
